Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Hidden Blood in Stool May Indicate Higher All-Cause Death Risk
From - Diagnostic Testing & Emerging Technologies
"Invisible" blood in stool may predict death from a wide range of causes, not just colorectal cancer, according to a study published July 16 in…
HBA1c Blood Test May ID Gestational Diabetes Risk in First Trimester
From - Diagnostic Testing & Emerging Technologies
First trimester HbA1c may aid in early identification of at women at risk of gestational diabetes (GD), according to a study published in Scientific Reports. Such early screening could…
Cost Avoidance vs Cost Savings: What’s the Difference?
By Jennifer Dawson, MHA, DLM (ASCP) bio
As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to demonstrate…
Targeted Sequencing Panel May Aid Diagnosis of Movement Disorders
...
Already a member? Log in here
FDA Issues Warning for ‘Over Reliance’ on Rupture of Membrane Tests
...
Already a member? Log in here
Mailed Kits Can Up Colorectal Screening at Community Health Clinics
...
Already a member? Log in here
With New FDA Input, Momentum for LDT Regulation Accelerating
...
Already a member? Log in here
High-Sensitivity Troponin Test Rules Out Heart Attacks Faster
From - Diagnostic Testing & Emerging Technologies
Use of a high-sensitivity cardiac troponin test (hs-cTnT) may be able to more quickly determine whether emergency department patients are having…
Whole-Genome Sequencing Adds Value to Cardiomyopathy Workup
From - Diagnostic Testing & Emerging Technologies
Whole-genome sequencing (WGS) identifies additional genetic causes of hypertrophic cardiomyopathy (HCM) beyond those identified through targeted…
Noninvasive Gene Expression Test for Melanoma Cuts Costs
From - Diagnostic Testing & Emerging Technologies
The noninvasive pigmented lesion assay (PLA; DermTech) reduces costs compared to the current standard of care for diagnostic workup of pigmented skin lesions suggestive of…